Published in Front Bioeng Biotechnol on August 24, 2015
Targeting transcription is no longer a quixotic quest. Nat Chem Biol (2015) 0.77
Supramolecular chemistry targeting proteins. J Am Chem Soc (2017) 0.75
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. J Mol Biol (1965) 46.35
Mass spectrometry-based proteomics. Nature (2003) 28.94
Towards a proteome-scale map of the human protein-protein interaction network. Nature (2005) 24.76
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature (2005) 22.40
Proteome survey reveals modularity of the yeast cell machinery. Nature (2006) 20.77
How many drug targets are there? Nat Rev Drug Discov (2006) 14.22
The druggable genome. Nat Rev Drug Discov (2002) 13.61
A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (1994) 11.50
The structural basis for 14-3-3:phosphopeptide binding specificity. Cell (1997) 10.87
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12
Dynamic personalities of proteins. Nature (2007) 8.92
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer (2006) 8.83
The dynamic energy landscape of dihydrofolate reductase catalysis. Science (2006) 7.55
Interactome networks and human disease. Cell (2011) 7.16
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov (2009) 6.69
The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J Med Chem (2004) 6.50
Intrinsic motions along an enzymatic reaction trajectory. Nature (2007) 5.53
Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J (2000) 5.22
p53 mutations in cancer. Nat Cell Biol (2013) 5.18
Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer (2009) 5.12
Rational design of inhibitors that bind to inactive kinase conformations. Nat Chem Biol (2006) 5.03
The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol (2001) 4.92
Surface, subunit interfaces and interior of oligomeric proteins. J Mol Biol (1988) 4.80
Analysis of protein complexes using mass spectrometry. Nat Rev Mol Cell Biol (2007) 4.70
A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 4.69
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci U S A (2006) 4.68
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature (2013) 4.43
Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov (2004) 4.19
Scaffold proteins: hubs for controlling the flow of cellular information. Science (2011) 4.00
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science (1993) 3.88
The art of the chemical probe. Nat Chem Biol (2010) 3.85
Visualization of transient encounter complexes in protein-protein association. Nature (2006) 3.77
X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell (1995) 3.68
Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc Natl Acad Sci U S A (2004) 3.59
Mass spectrometric-based approaches in quantitative proteomics. Methods (2003) 3.38
A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol (2012) 3.32
Crystal structure of the nucleotide exchange factor GrpE bound to the ATPase domain of the molecular chaperone DnaK. Science (1997) 3.31
Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol (2005) 3.25
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. Anal Biochem (2004) 3.02
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ (2006) 2.95
Ras signaling and therapies. Adv Cancer Res (2009) 2.93
Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol Pharmacol (2006) 2.69
Site-directed ligand discovery. Proc Natl Acad Sci U S A (2000) 2.58
From the cradle to the grave: molecular chaperones that may choose between folding and degradation. EMBO Rep (2001) 2.55
Interactome modeling. FEBS Lett (2005) 2.41
Tethering: fragment-based drug discovery. Annu Rev Biophys Biomol Struct (2004) 2.37
Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature (2012) 2.21
Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem (2010) 2.21
Selective methyl group protonation of perdeuterated proteins. J Mol Biol (1996) 2.15
A common allosteric site and mechanism in caspases. Proc Natl Acad Sci U S A (2006) 2.12
Transient protein-protein interactions: structural, functional, and network properties. Structure (2010) 2.07
Global folds of highly deuterated, methyl-protonated proteins by multidimensional NMR. Biochemistry (1997) 1.99
Yeast two-hybrid contributions to interactome mapping. Curr Opin Biotechnol (2006) 1.98
Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. Neuropharmacology (2010) 1.97
Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Chem Biol (2014) 1.95
Chemical screens against a reconstituted multiprotein complex: myricetin blocks DnaJ regulation of DnaK through an allosteric mechanism. Chem Biol (2011) 1.89
Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry? Mol Cancer Res (2009) 1.87
Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell (1996) 1.84
14-3-3 proteins in cell cycle regulation. Semin Cancer Biol (2006) 1.83
Transcription activator interactions with multiple SWI/SNF subunits. Mol Cell Biol (2002) 1.82
Protein identification by tandem mass spectrometry and sequence database searching. Methods Mol Biol (2007) 1.82
Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay. Mol Pharmacol (2006) 1.78
Binding of small molecules to an adaptive protein-protein interface. Proc Natl Acad Sci U S A (2003) 1.78
Malleable machines take shape in eukaryotic transcriptional regulation. Nat Chem Biol (2008) 1.76
Structural basis for cooperative transcription factor binding to the CBP coactivator. J Mol Biol (2005) 1.75
Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem J (2010) 1.73
Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc Natl Acad Sci U S A (2002) 1.72
Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol (2010) 1.68
Protein photo-cross-linking in mammalian cells by site-specific incorporation of a photoreactive amino acid. Nat Methods (2005) 1.67
Structure of a 14-3-3 coordinated hexamer of the plant plasma membrane H+ -ATPase by combining X-ray crystallography and electron cryomicroscopy. Mol Cell (2007) 1.67
Structural view of a fungal toxin acting on a 14-3-3 regulatory complex. EMBO J (2003) 1.67
High-throughput screen for small molecules that modulate the ATPase activity of the molecular chaperone DnaK. Anal Biochem (2007) 1.65
Expanding dialogues: from natural autoinducers to non-natural analogues that modulate quorum sensing in Gram-negative bacteria. Chem Soc Rev (2008) 1.62
A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. J Med Chem (2011) 1.58
In vivo incorporation of unnatural amino acids to probe structure, dynamics, and ligand binding in a large protein by nuclear magnetic resonance spectroscopy. J Am Chem Soc (2008) 1.57
Dynamics of methyl groups in proteins as studied by proton-detected 13C NMR spectroscopy. Application to the leucine residues of staphylococcal nuclease. Biochemistry (1992) 1.56
p53 Activation by small molecules: application in oncology. J Med Chem (2005) 1.55
Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. Genes Dev (2002) 1.53
Pharmacological targeting of the Hsp70 chaperone. Curr Top Med Chem (2009) 1.51
Methyl groups as probes of structure and dynamics in NMR studies of high-molecular-weight proteins. Chembiochem (2005) 1.48
Heat shock protein 70 kDa chaperone/DnaJ cochaperone complex employs an unusual dynamic interface. Proc Natl Acad Sci U S A (2011) 1.47
The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions. Curr Opin Chem Biol (2009) 1.46
Function of a conserved sequence motif in biotin holoenzyme synthetases. Protein Sci (2000) 1.44
Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta. Chem Biol (2007) 1.44
Protein-protein interaction detection in vitro and in cells by proximity biotinylation. J Am Chem Soc (2008) 1.38
In vivo photocrosslinking with unnatural amino Acid mutagenesis. Chembiochem (2002) 1.38
Probing nuclear pore complex architecture with proximity-dependent biotinylation. Proc Natl Acad Sci U S A (2014) 1.38
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation. Nat Chem Biol (2012) 1.37
Integrative, dynamic structural biology at atomic resolution--it's about time. Nat Methods (2015) 1.36
Turning a protein kinase on or off from a single allosteric site via disulfide trapping. Proc Natl Acad Sci U S A (2011) 1.33
Direct observation of the dynamic process underlying allosteric signal transmission. J Am Chem Soc (2009) 1.32
Structural basis of acyl-homoserine lactone-dependent signaling. Chem Rev (2010) 1.30
Affinity-purification coupled to mass spectrometry: basic principles and strategies. Proteomics (2012) 1.30
Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation. J Biol Chem (2010) 1.29
Binding of a small molecule at a protein-protein interface regulates the chaperone activity of hsp70-hsp40. ACS Chem Biol (2010) 1.28
Role of PDZ proteins in regulating trafficking, signaling, and function of GPCRs: means, motif, and opportunity. Adv Pharmacol (2011) 1.27
Gas-phase unfolding and disassembly reveals stability differences in ligand-bound multiprotein complexes. Chem Biol (2009) 1.27
Current applications of 19F NMR to studies of protein structure and dynamics. Prog Nucl Magn Reson Spectrosc (2011) 1.25
MLL fusions: pathways to leukemia. Cancer Biol Ther (2009) 1.24